Heterogeneity of treatment effect of higher dose dexamethasone by geographic region (Europe vs. India) in patients with COVID-19 and severe hypoxemia – a post hoc evaluation of the COVID STEROID 2 trial

MLA

Tirupakuzhi Vijayaraghavan, Bharath Kumar, et al. “Heterogeneity of Treatment Effect of Higher Dose Dexamethasone by Geographic Region (Europe vs. India) in Patients with COVID-19 and Severe Hypoxemia – a Post Hoc Evaluation of the COVID STEROID 2 Trial.” Tirupakuzhi Vijayaraghavan , B K , Granholm , A , Munch , M W , Kjær , M B N , Møller , M H , Perner , A , Myatra , S N , Jha , V , Jha , V , Jha , V , Hammond , N , Micallef , S , Venkatesh , B , Hammond , N , Lange , T , Munch , M W , Myatra , S N , Tirupakuzhi Vijayaraghavan , B K , Saseedharan , S , Benfield , T , Wahlin , R R , Rasmussen , B S , Andreasen , A S , Poulsen , L M , Cioccari , L , Khan , M S , Kapadia , F , Divatia , J V , Brøchner , A C , Bestle , M H , Helleberg , M , Michelsen , J , Padmanaban , A , Bose , N , Møller , A , Borawake , K , Kristiansen , K T , Shukla , U , Chew , M S , Ulrik , C S , Kjær , M B N , Møller , M H , Meyhoff , T S , Vesterlund , G K , Gluud , C , Lange , T , Marcussen , K V , Nielsen , H , Jensen , T S , Perner , A & the COVID-STEROID 2 Collaborators 2024 , ’ Heterogeneity of Treatment Effect of Higher Dose Dexamethasone by Geographic Region (Europe vs. India) in Patients with COVID-19 and Severe Hypoxemia – a Post Hoc Evaluation of the COVID STEROID 2 Trial ’ , The Lancet Regional Health - Southeast Asia , Vol. 20 , 100293 , 2024. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1439555188&authtype=sso&custid=ns315887.

APA

Tirupakuzhi Vijayaraghavan, B. K., Granholm, A., Munch, M. W., Kjær, M. B. N., Møller, M. H., Perner, A., Myatra, S. N., Jha, V., Hammond, N., Micallef, S., Venkatesh, B., Lange, T., Saseedharan, S., Benfield, T., Wahlin, R. R., Rasmussen, B. S., Andreasen, A. S., Poulsen, L. M., Cioccari, L., … Jensen, T. S. (2024). Heterogeneity of treatment effect of higher dose dexamethasone by geographic region (Europe vs. India) in patients with COVID-19 and severe hypoxemia – a post hoc evaluation of the COVID STEROID 2 trial. Tirupakuzhi Vijayaraghavan , B K , Granholm , A , Munch , M W , Kjær , M B N , Møller , M H , Perner , A , Myatra , S N , Jha , V , Jha , V , Jha , V , Hammond , N , Micallef , S , Venkatesh , B , Hammond , N , Lange , T , Munch , M W , Myatra , S N , Tirupakuzhi Vijayaraghavan , B K , Saseedharan , S , Benfield , T , Wahlin , R R , Rasmussen , B S , Andreasen , A S , Poulsen , L M , Cioccari , L , Khan , M S , Kapadia , F , Divatia , J V , Brøchner , A C , Bestle , M H , Helleberg , M , Michelsen , J , Padmanaban , A , Bose , N , Møller , A , Borawake , K , Kristiansen , K T , Shukla , U , Chew , M S , Ulrik , C S , Kjær , M B N , Møller , M H , Meyhoff , T S , Vesterlund , G K , Gluud , C , Lange , T , Marcussen , K V , Nielsen , H , Jensen , T S , Perner , A & the COVID-STEROID 2 Collaborators 2024 , ’ Heterogeneity of Treatment Effect of Higher Dose Dexamethasone by Geographic Region (Europe vs. India) in Patients with COVID-19 and Severe Hypoxemia – a Post Hoc Evaluation of the COVID STEROID 2 Trial ’ , The Lancet Regional Health - Southeast Asia , Vol. 20 , 100293 .

Chicago

Tirupakuzhi Vijayaraghavan, Bharath Kumar, Anders Granholm, Marie W. Munch, Maj Brit N. Kjær, Morten H. Møller, Anders Perner, Sheila N. Myatra, et al. 2024. “Heterogeneity of Treatment Effect of Higher Dose Dexamethasone by Geographic Region (Europe vs. India) in Patients with COVID-19 and Severe Hypoxemia – a Post Hoc Evaluation of the COVID STEROID 2 Trial.” Tirupakuzhi Vijayaraghavan , B K , Granholm , A , Munch , M W , Kjær , M B N , Møller , M H , Perner , A , Myatra , S N , Jha , V , Jha , V , Jha , V , Hammond , N , Micallef , S , Venkatesh , B , Hammond , N , Lange , T , Munch , M W , Myatra , S N , Tirupakuzhi Vijayaraghavan , B K , Saseedharan , S , Benfield , T , Wahlin , R R , Rasmussen , B S , Andreasen , A S , Poulsen , L M , Cioccari , L , Khan , M S , Kapadia , F , Divatia , J V , Brøchner , A C , Bestle , M H , Helleberg , M , Michelsen , J , Padmanaban , A , Bose , N , Møller , A , Borawake , K , Kristiansen , K T , Shukla , U , Chew , M S , Ulrik , C S , Kjær , M B N , Møller , M H , Meyhoff , T S , Vesterlund , G K , Gluud , C , Lange , T , Marcussen , K V , Nielsen , H , Jensen , T S , Perner , A & the COVID-STEROID 2 Collaborators 2024 , ’ Heterogeneity of Treatment Effect of Higher Dose Dexamethasone by Geographic Region (Europe vs. India) in Patients with COVID-19 and Severe Hypoxemia – a Post Hoc Evaluation of the COVID STEROID 2 Trial ’ , The Lancet Regional Health - Southeast Asia , Vol. 20 , 100293 . http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1439555188&authtype=sso&custid=ns315887.